NIH Consensus Development Conference:
Inhaled Nitric Oxide Therapy
for Premature Infants
October 27-29, 2010
Bethesda, Maryland
Conference Home
Final Statement
Program & Abstracts | PDF
Archived Webcast Day 1 | 2 | 3
Evidence Report
Planning Committee | Panel
Media Resources
Planning Committee
The planning committee was comprised of the conference panel chairperson, representatives from the sponsoring NIH Institute (the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD), the Office of Medical Applications of Research, the contracting Agency for the conference systematic evidence review (the Agency for Healthcare Research and Quality, AHRQ), and other related Federal entities. Additionally, recognized non-Federal key experts in the field were also invited to serve on the planning committee, to accomplish the following six functions:
- Draft the conference questions
- Draft the conference agenda
- Nominate potential conference speakers
- Nominate potential panel members
- Title the conference
- Set the conference date
Planning Committee members listed below provided their input at a meeting held April 19–21, 2009. The information provided here was accurate at the time of that meeting.
Rosemary D. Higgins, M.D.
|
Barnett S. Kramer, M.D., M.P.H.
|
| Learn more about the NIH Consensus Development Program | ||
| Join the Consensus Development Program Information Network | ||
![]() |
Contact us with any questions or comments | |
Kelli Marciel, Communications Director |
||
neilsone@mail.nih.gov | 301-496-4999< |
||
Contact Consensus Program |
Privacy Notice |
Disclaimer |
Accessibility |
Contact NIH

![]()
![]()
![]()


